AMLX
Price
$5.15
Change
+$0.25 (+5.10%)
Updated
May 30 closing price
Capitalization
459.08M
66 days until earnings call
PYPD
Price
$3.00
Change
+$0.20 (+7.14%)
Updated
Jun 2, 10:34 AM (EDT)
Capitalization
28.53M
65 days until earnings call
Interact to see
Advertisement

AMLX vs PYPD

Header iconAMLX vs PYPD Comparison
Open Charts AMLX vs PYPDBanner chart's image
Amylyx Pharmaceuticals
Price$5.15
Change+$0.25 (+5.10%)
Volume$1.39M
Capitalization459.08M
PolyPid
Price$3.00
Change+$0.20 (+7.14%)
Volume$333
Capitalization28.53M
AMLX vs PYPD Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. PYPD commentary
Jun 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and PYPD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 02, 2025
Stock price -- (AMLX: $5.15 vs. PYPD: $2.80)
Brand notoriety: AMLX and PYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 149% vs. PYPD: 216%
Market capitalization -- AMLX: $459.08M vs. PYPD: $28.53M
AMLX [@Biotechnology] is valued at $459.08M. PYPD’s [@Biotechnology] market capitalization is $28.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whilePYPD’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • PYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than PYPD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while PYPD’s TA Score has 6 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 4 bearish.
  • PYPD’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PYPD is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а -3.01% price change this week, while PYPD (@Biotechnology) price change was +0.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

PYPD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($459M) has a higher market cap than PYPD($28.5M). AMLX YTD gains are higher at: 36.243 vs. PYPD (-7.895). PYPD has higher annual earnings (EBITDA): -26.41M vs. AMLX (-206.81M). AMLX has more cash in the bank: 204M vs. PYPD (15.6M). AMLX has less debt than PYPD: AMLX (1.38M) vs PYPD (9.62M). PYPD has higher revenues than AMLX: PYPD (0) vs AMLX (-1.27M).
AMLXPYPDAMLX / PYPD
Capitalization459M28.5M1,611%
EBITDA-206.81M-26.41M783%
Gain YTD36.243-7.895-459%
P/E Ratio2.69N/A-
Revenue-1.27M0-
Total Cash204M15.6M1,308%
Total Debt1.38M9.62M14%
TECHNICAL ANALYSIS
Technical Analysis
AMLXPYPD
RSI
ODDS (%)
Bearish Trend 4 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
73%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
71%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTPSX81.970.23
+0.28%
Invesco Technology R6
MXVIX37.95N/A
N/A
Empower S&P 500® Index Investor
PLIEX29.83-0.01
-0.03%
Plumb Equity Institutional
BCSAX8.92-0.03
-0.34%
BlackRock Commodity Strategies Inv A
HOOTX28.52-0.12
-0.42%
Hartford Schroders US Small Cap Opps R5

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+5.10%
XOMAO - AMLX
68%
Closely correlated
-0.43%
IKNA - AMLX
54%
Loosely correlated
+0.85%
XOMAP - AMLX
51%
Loosely correlated
-0.17%
RGNX - AMLX
48%
Loosely correlated
-1.34%
JAZZ - AMLX
43%
Loosely correlated
-0.18%
More

PYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYPD has been loosely correlated with VTYX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PYPD jumps, then VTYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+0.36%
VTYX - PYPD
37%
Loosely correlated
-6.08%
AMLX - PYPD
29%
Poorly correlated
+5.10%
MESO - PYPD
29%
Poorly correlated
-0.37%
INM - PYPD
28%
Poorly correlated
+1.63%
VRAX - PYPD
28%
Poorly correlated
+0.47%
More